Weill Cornell has earned a distinguished three-star rating – the top rating – from The Society of Thoracic Surgeons (STS) for its patient care and outcomes in isolated coronary artery bypass grafting (CABG) procedures and Mitral Valve Repair and Replacement for the 3 year period 2021 thru 2023. The three-star rating, which denotes the highest category of quality, places Weill Cornell Medicine among the elite for heart bypass surgery and mitral valve surgery in the United States and Canada. Additionally, the Weill Cornell program at NewYork-Presbyterian Queens has earned a distinguished three-star rating for its patient care and outcomes in isolated coronary artery bypass grafting (CABG) procedures.
STS, a nonprofit organization representing more than 7,600 surgeons, researchers and healthcare professionals worldwide, developed a comprehensive rating system that evaluates the quality of cardiac surgical procedures performed at hospitals across the country. The STS star rating system is one of the most sophisticated and highly regarded overall measures of quality in health care, rating the benchmarked outcomes of cardiothoracic surgery programs across the United States and Canada. The latest analysis of data for cardiac surgery covers a 3-year period, from January 2021 to December 2023.
“We are delighted to be recognized by The Society of Thoracic Surgeons as a distinguished provider of bypass surgery and mitral valve surgery for our patients,” said Dr. Leonard Girardi, Chair, Department of Cardiothoracic Surgery at Weill Cornell Medicine. “This achievement is a testament to our commitment to providing the highest quality cardiovascular care to our patients at all Weill Cornell campuses.”